New insights of LncRNAs fingerprints in breast cancer progression: Tumorigenesis, drug resistance, and therapeutic opportunities

被引：2

作者：

Hussen, Bashdar Mahmud ^{[1
,2
]}

Othman, Diyar Idris ^{[1
]}

Abdullah, Snur Rasool ^{[2
]}

Khudhur, Zhikal Omar ^{[3
]}

Samsami, Majid ^{[4
]}

Taheri, Mohammad ^{[5
,6
]}

机构：

[1] Hawler Med Univ, Coll Pharm, Dept Clin Anal, Erbil 44001, Kurdistan Regio, Iraq

[2] Lebanese French Univ, Coll Hlth Sci, Dept Med Lab Sci, Erbil, Kurdistan Regio, Iraq

[3] Tishk Int Univ, Fac Educ, Dept Biol, Erbil, Kurdistan Regio, Iraq

[4] Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran

[5] Jena Univ Hosp, Inst Human Genet, Jena, Germany

[6] Shahid Beheshti Univ Med Sci, Res Inst Urol & Nephrol, Urol & Nephrol Res Ctr, Tehran, Iran

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES | 2025年 / 287卷

关键词：

Keywords; Breast cancer; LncRNAs; Tumorigenesis; Drug resistance; Clinical trial; LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; CELL-PROLIFERATION; PROMOTES PROLIFERATION; ADRIAMYCIN RESISTANCE; UP-REGULATION; INVASION; MIGRATION; METASTASIS;

D O I：

10.1016/j.ijbiomac.2024.138589

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Breast cancer (BC) is one of the common female cancers and it is characterized by considerable problems regarding its development and therapy. Long non-coding RNAs (lncRNAs) have been identified as significant modulators in BC development, especially, in tumorigenicity and chemoresistance. We therefore endeavor to present an up-to-date understanding of lncRNAs and their impact on BC progression and treatment, concerning molecular processes, treatment options, and use as a therapeutic opportunity. LncRNAs are novel regulators of genes that cause therapeutic resistance and directly impact the functioning of both coding and non-coding genes in BC patients, but little is known about their mechanisms of actions. Thus, additional study is required to have a deeper understanding of their modes of action and possible roles in BC disease. This study aims to investigate the functions of lncRNAs in the development of BC, with particular attention to their role in tumorigenesis, drug resistance mechanisms, and therapeutic targets. This will help to identify novel therapeutic targets and improve the effectiveness of BC treatment.

引用

页数：29

共 50 条

[11] Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies [J].

Mehmandar-Oskuie, Amirreza ;

Jahankhani, Kasra ;

Rostamlou, Arman ;

Arabi, Sepideh ;

Razavi, Zahra Sadat ;

Mardi, Amirhossein .

BIOMEDICINE & PHARMACOTHERAPY, 2023, 165

[12] Neutrophils in cancer drug resistance: Roles and therapeutic opportunities [J].

Liu, Hao ;

Zhao, Hongyu ;

Zhou, Mingzhen ;

Zhao, Xiaodi ;

Lu, Yuanyuan .

CANCER LETTERS, 2025, 611

[13] Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets [J].

Hussen, Bashdar Mahmud ;

Mohamadtahr, Sayran ;

Abdullah, Snur Rasool ;

Hidayat, Hazha Jamal ;

Rasul, Mohammad Fatih ;

Hama Faraj, Goran Sedeeq ;

Ghafouri-Fard, Soudeh ;

Taheri, Mohammad ;

Khayamzadeh, Maryam ;

Jamali, Elena .

FRONTIERS IN GENETICS, 2023, 14

[14] Crosstalk between lncRNAs and Wnt/β-catenin signaling pathways in lung cancers: From cancer progression to therapeutic response [J].

Wu, Ting ;

Dong, YiRan ;

Yang, XinZhi ;

Mo, Liang ;

You, Yong .

NON-CODING RNA RESEARCH, 2024, 9 (03) :667-677

[15] The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer [J].

Ye, Pingting ;

Feng, Lei ;

Shi, Shuo ;

Dong, Chunyan .

CANCERS, 2022, 14 (09)

[16] Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities [J].

Xiong, Hanchu ;

Zhao, Wenhe ;

Wang, Ji ;

Seifer, Benjamin J. ;

Ye, Chenyang ;

Chen, Yongxia ;

Jia, Yunlu ;

Chen, Cong ;

Shen, Jianguo ;

Wang, Linbo ;

Sui, Xinbing ;

Zhou, Jichun .

ONCOTARGET, 2017, 8 (15) :25721-25735

[17] Subcellular localization of hTERT in breast cancer: insights into its tumorigenesis and drug resistance mechanisms in HER2-immunopositive breast cancer [J].

Uno, Yuji ;

Tanaka, Hiroki ;

Miyakawa, Keita ;

Akiyama, Naoko ;

Kamikokura, Yuki ;

Yuzawa, Sayaka ;

Kitada, Masahiro ;

Takei, Hidehiro ;

Tanino, Mishie .

HUMAN PATHOLOGY, 2023, 134 :74-84

[18] Inflammation in cancer: therapeutic opportunities from new insights [J].

Xie, Yifei ;

Liu, Fangfang ;

Wu, Yunfei ;

Zhu, Yuer ;

Jiang, Yanan ;

Wu, Qiong ;

Dong, Zigang ;

Liu, Kangdong .

MOLECULAR CANCER, 2025, 24 (01)

[19] Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities [J].

Ramamoorthi, Ganesan ;

Kodumudi, Krithika ;

Gallen, Corey ;

Zachariah, Nadia Nocera ;

Basu, Amrita ;

Albert, Gabriella ;

Beyer, Amber ;

Snyder, Colin ;

Wiener, Doris ;

Costa, Ricardo L. B. ;

Czerniecki, Brian J. .

SEMINARS IN CANCER BIOLOGY, 2022, 78 :78-89

[20] LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer [J].

Bermudez, Mercedes ;

Aguilar-Medina, Maribel ;

Lizarraga-Verdugo, Erik ;

Avendano-Felix, Mariana ;

Silva-Benitez, Erika ;

Lopez-Camarillo, Cesar ;

Ramos-Payan, Rosalio .

FRONTIERS IN ONCOLOGY, 2019, 9

← 1 2 3 4 5 →